Modeling the relationship between emotion regulation, intolerance of uncertainty, and psychological distress in patients with cancer is one of the important topics in contemporary psycho-oncology research, because the experience of cancer is associated with health threats, uncertainty about the future, physical changes, and frequent exposure to unpredictable situations. The patient may face questions about the effectiveness of treatment, the likelihood of recurrence, the duration of treatment, drug side effects, future physical condition, job and family performance, and quality of life, many of which do not have definitive and immediate answers. This situation can create a significant level of uncertainty and lead to persistent worry and increased psychological distress in people who have a lower tolerance for uncertainty and unpredictability. In such situations, how emotion is regulated can determine how a person faces this uncertainty, processes worrying thoughts, and manages their emotional reactions.
Intolerance of uncertainty is one of the important cognitive-emotional variables in explaining psychological distress in patients with cancer. This construct refers to a person's tendency to experience uncertain situations as unbearable, threatening, or very difficult. A patient with high intolerance of uncertainty may still not be able to separate his mind from possible future scenarios even in situations where the probability of a negative outcome is low. Waiting for the test result, taking imaging, determining the response to treatment, or the interval between two treatment periods can become a serious source of worry for such a person. In this situation, the mind may try to create a sense of control by constantly anticipating the future and repeatedly examining the symptoms, but this effort sometimes leads to increased worry, rumination, and psychological exhaustion.
Psychological distress in patients with cancer also has a broader concept than a specific mental disorder and can include anxiety, sadness, fear, worry, feelings of helplessness, sleep problems, disruption in social relationships, and practical and economic concerns. The severity of distress is not constant along the course of the disease and may increase at the time of diagnosis, initiation of treatment, change of treatment protocol, receipt of test results, end of treatment, or exposure to the possibility of recurrence. For this reason, psychological distress is considered in psychooncology as one of the important indicators of the need for psychological assessment and support. Identifying the factors that can predict or explain distress allows for the design of more precise and targeted interventions.
Emotion regulation can play a decisive role in this regard. Emotion regulation refers to the set of processes through which a person manages the intensity, duration, direction, and manner in which they express their emotions. In the face of cancer, adaptive emotion regulation does not mean denying fear or being compelled to think positively, but rather involves accepting difficult emotions, recognizing them, using appropriate strategies, and preventing natural reactions from turning into stable and debilitating patterns. Strategies such as cognitive reassessment, acceptance, and problem-solving can help the patient create a more realistic meaning of the situation, while strategies such as emotional repression, rumination, and avoidance may be associated with increased distress in some situations.
From a modeling perspective, the relationship between these three variables can be considered in the form of an interactive system. Intolerance of uncertainty may be directly related to increased psychological distress, as the patient cannot easily cope with the lack of a definitive answer about the future. On the other hand, emotion regulation can moderate or mediate this relationship, meaning that the way a person deals with the emotions of uncertainty may change the severity of the effect of uncertainty on distress. For example, two patients may face the same level of uncertainty about the outcome of treatment, but a patient who uses acceptance, cognitive reassessment, and problem-solving may experience less distress, while a patient who is more involved in emotion suppression, avoidance, or rumination may have a more intense psychological response.
This model can be explained based on cognitive and process perspectives of emotion regulation. In this view, the external event alone does not determine the emotional response, but rather the individual's assessment of the event and the strategies he or she employs to manage it. Cancer is inherently associated with levels of uncertainty and it is not possible to eliminate it completely; therefore, the psychological goal cannot be to eliminate all uncertainty, but rather to increase the patient's capacity to tolerate and manage it. If the patient can accept that some questions do not currently have definitive answers, focus on controllable areas, and manage their emotional reactions without excessive avoidance, the likelihood of reducing distress increases.
Research evidence in the field of psycho-oncology has shown that illness-related uncertainty can be associated with anxiety, depression, fear of relapse, and decreased quality of life. Also, maladaptive patterns of emotion regulation have been shown to be more associated with psychological distress in many studies. However, the relationship between these variables is not simple and linear, and factors such as type of cancer, stage of the disease, prognosis, age, social support, economic status, history of psychological problems, and the quality of the patient's relationship with the treatment team can also affect it. Therefore, structural modeling can provide a more accurate picture of the interaction of cognitive and emotional variables than examining binary relationships.
One of the important applications of such a model in psycho-oncology is to identify vulnerable patients prior to the exacerbation of distress. If it is found that uncertainty intolerance plays an important role in increasing distress , and emotion regulation also plays a mediating or moderating role in this regard, the assessment of these variables can become part of the psychological screening process. In this case, the specialist can identify patients who have a more severe reaction to uncertainty earlier and consider more targeted interventions for them. Such an approach becomes especially important during periods such as waiting for test results, imaging, response to treatment, or assessing the likelihood of relapse.
Therapeutically, the results of such models can help design specific interventions to increase uncertainty tolerance and improve emotion regulation. Cognitive-behavioral interventions can identify and reconstruct catastrophic thoughts about the future and help the patient distinguish between "not knowing" and "the definitive occurrence of a negative outcome." Acceptance training, mindfulness awareness, and distress tolerance skills can also increase a person's capacity to remain in uncertain situations without severe avoidance reactions. Problem-solving training can also help the patient differentiate between issues that are manageable and those that are currently out of their control.
In the meantime, therapeutic communication and the quality of receiving medical information are also important. Part of the patient's uncertainty may be due to a lack of information, inappropriate communication, or difficulty in understanding the treatment process. Providing clear, staged, and tailored information to the patient's needs can reduce unnecessary ambiguity. Of course, medical information cannot eliminate all cancer uncertainties, but it can prevent uncertainty caused by misunderstandings. Collaboration between medical and psychological professionals can also help the patient both receive the scientific information they need and be emotionally prepared to face it.
One of the major challenges in examining this model is the difference between intolerance of uncertainty and normal anxiety caused by cancer. Waiting for the outcome of treatment or worrying about the future is partly a natural reaction to a serious illness and should not be considered a psychological problem. Clinical significance increases when the worry becomes significant in intensity and persistence, interferes with daily functioning, or leads to avoidance, insomnia, rumination, and reduced participation in treatment. Therefore, the interpretation of the scores of the measurement tools should always be done in the context of the patient's medical condition and real-life circumstances.
Another limitation relates to the nature of correlational and cross-sectional studies. Although the existence of a relationship between uncertainty intolerance, emotion regulation, and psychological distress can support a theoretical model, a statistical relationship alone does not prove a cause-and-effect relationship. Longitudinal studies can determine whether increased intolerance of uncertainty in the early stages of the disease really predicts a subsequent increase in distress and whether improved emotion regulation can change this trajectory. Also, the use of structural equation modeling, mediating and moderation analysis, and multi-stage measurements can provide a more accurate understanding of the relationships between variables.
From a research point of view, it is suggested that future models consider variables such as social support, self-efficacy, resilience, fear of relapse, quality of communication with the physician, meaning-finding of the disease, and quality of life. It is also necessary to consider the differences between the types of cancer and the different stages of treatment, as the experience of uncertainty in the patient undergoing chemotherapy may be different from the person who is in the follow-up phase after treatment. Cultural studies are also important, as the way in which uncertainty and emotion are experienced and expressed can be influenced by family, social, and cultural beliefs.
Modeling the relationship between emotion regulation, uncertainty intolerance, and psychological distress can provide a valuable framework for understanding some of the psychological mechanisms of the cancer experience. In this framework, cancer is not only a physical threat, but also a situation with uncertainty and emotional stress, and the patient's psychological response is largely influenced by how this uncertainty is processed and the way emotion is regulated. Intolerance of uncertainty can increase the context of worry and distress, while adaptive emotion regulation can increase the patient's capacity to face difficult emotions and uncertain situations. Accordingly, simultaneously paying attention to these three variables in psycho-oncology assessment and interventions can help identify vulnerable patients early, design personalized interventions, and promote psychological adaptation in the course of the disease. The ultimate goal of such an approach is not to completely eliminate fear, worry, or uncertainty, but rather to increase the patient's capacity to live and make effective decisions in situations where part of the future remains uncertain.